NCT00005795View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Leukemia
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00005795 - Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter